When human gastric adenocarcinomas were dual-labeled with antibodies, formation of LC3 and immunoreactivity against cathepsin B markedly increased compared with normal tissues (Fig. 3). This evidence concerns the gene MAP1LC3A and gastric adenocarcinoma.